Healthcare -
Medical - Devices - NYSE - US
$ 71.14
-0.0993 %
$ 9.63 B
Market Cap
93.91
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Globus Medical, Inc.
| Net Income | 103 M |
| Depreciation & Amortization | 254 M |
| Capital Expenditures | -115 M |
| Stock-Based Compensation | 54.2 M |
| Change in Working Capital | 0 |
| Others | 235 M |
| Free Cash Flow | 405 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||
| Net Income | 103.0 | 122.9 | 190.2 | 149.2 | 102.3 | 155.2 | 156.5 | 107.3 | 104.3 | 112.8 | 92.5 | 68.6 | 73.8 | 60.8 | 54.5 | 52.0 |
| Depreciation & Amortization | 254.0 | 144.7 | 68.3 | 69.9 | 62.9 | 52.7 | 41.6 | 42.1 | 38.8 | 24.1 | 21.8 | 19.4 | 18.1 | 16.9 | 15.2 | 13.5 |
| Deferred Income Tax | (125.9) | (57.8) | (22.2) | (17.6) | (4.3) | 4.3 | 1.0 | 8.3 | (3.8) | 6.2 | (4.4) | (14.9) | (6.1) | 2.1 | 2.0 | (2.7) |
| Stock Based Compensation | 54.2 | 52.7 | 32.8 | 30.6 | 27.1 | 26.1 | 21.9 | 14.7 | 11.4 | 9.6 | 7.1 | 5.2 | 4.6 | 3.3 | 4.0 | 3.5 |
| Other Operating Activities | 235.3 | 97.5 | 14.7 | 61.5 | 48.5 | 7.1 | 10.5 | 17.7 | 17.7 | 12.7 | 10.0 | 8.9 | 6.6 | 10.6 | 6.3 | 5.4 |
| Change in Working Capital | 0 | (116.6) | (105.3) | (17.3) | (37.6) | (73.4) | (49.9) | (30.5) | 3.5 | (43.5) | (47.8) | 6.2 | (20.6) | (17.3) | (10.7) | (39.7) |
| Cash From Operations | 520.6 | 243.5 | 178.5 | 276.3 | 198.8 | 172.0 | 181.6 | 159.5 | 171.9 | 122.0 | 79.2 | 93.5 | 76.5 | 76.4 | 71.3 | 32.1 |
| INVESTING CASH FLOW | ||||||||||||||||
| Capital Expenditures | (115.4) | (78.3) | (74.0) | (56.9) | (63.7) | (70.8) | (59.7) | (51.3) | (40.9) | (50.8) | (24.8) | (23.7) | (24.7) | (22.5) | (12.3) | (26.0) |
| Other Items | (60.6) | 381.2 | (36.3) | (319.0) | (53.7) | (69.5) | (133.3) | (60.0) | (58.6) | (99.8) | (75.2) | (203.5) | (6.0) | (7.5) | 0.3 | (1.7) |
| Cash From Investing Activities | (176.1) | 303.0 | (110.4) | (375.9) | (117.3) | (140.3) | (193.0) | (111.3) | (99.6) | (150.6) | (100.0) | (227.2) | (30.7) | (30.0) | (12.0) | (27.7) |
| FINANCING CASH FLOW | ||||||||||||||||
| Common Stock Repurchased | (85.8) | (225.6) | (144.5) | 0 | (104.7) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (10.0) | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (5.3) | (0.3) | 0.3 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 58.1 | (6.3) | 34.5 | 54.1 | 66.0 | (6.6) | (6.7) | (10.1) | (5.4) | 0.8 | 3.2 | 3.5 | 1.6 | (0.3) | 0.8 | 0.2 |
| Cash From Financing Activities | (27.7) | (231.8) | (110.0) | 54.1 | (38.7) | 24.4 | 32.6 | 1.6 | 2.0 | 6.3 | 12.9 | 11.0 | 24.0 | (14.7) | 1.8 | 1.5 |
| CHANGE IN CASH | ||||||||||||||||
| Net Change In Cash | 317.1 | 316.8 | (42.6) | (46.3) | 43.7 | 56.0 | 20.9 | 51.9 | 72.5 | (22.1) | (7.7) | (122.4) | 69.7 | 31.0 | 61.1 | 5.9 |
| FREE CASH FLOW | ||||||||||||||||
| Free Cash Flow | 405.2 | 165.2 | 104.4 | 219.4 | 135.1 | 101.2 | 121.9 | 108.2 | 131.0 | 71.2 | 54.4 | 69.8 | 51.8 | 53.9 | 59.0 | 6.1 |